Showing results (591-600 of 2,448) with videos related to
Sort By:
Pageof 245
Experimental Neurology|August 19, 2007
Axial hypertonicity in Parkinson's disease: direct measurements of trunk and hip torqueW G Wright, V S Gurfinkel, J Nutt, et al.Archives of Suicide Research : Official Journal of the International Academy for Suicide Research|July 24, 2024
Suicidal Ideation in Medicinal Cannabis Patients: A 12-Month Prospective StudyM T Lynskey, H Thurgur, A Athanasiou-Fragkouli, et al.Scientific Reports|February 7, 2024
Effects of DMT on mental health outcomes in healthy volunteersChristopher Timmermann, Richard J Zeifman, David Erritzoe, et al.International Clinical Psychopharmacology|April 13, 2004
Evaluation of actigraphy and automated telephoned questionnaires to assess hypnotic effects in insomniaS J Wilson, A S Rich, N C Rich, et al.British Journal of Pharmacology|November 7, 1998
Potentiation of barbiturate-induced alterations in presynaptic noradrenergic function in rat frontal cortex by imidazol(in)e alpha2-adrenoceptor agonistsJ W Dalley, C A Parker, E Wülfert, et al.Psychiatry Research|March 1, 2015
Progress in mind: focus on alcohol use disorders, an elsevier resource centreD J Nutt, J Rehm, W van den Brink, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 10, 2014
Imaging endogenous opioid peptide release with [11C]carfentanil and [3H]diprenorphine: influence of agonist-induced internalizationDarren R Quelch, Loukia Katsouri, David J Nutt, et al.Neuropharmacology|December 31, 2017
Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depressionLeor Roseman, Lysia Demetriou, Matthew B Wall, et al.Journal of Psychopharmacology (Oxford, England)|November 27, 2009
Harms associated with psychoactive substances: findings of the UK National Drug SurveyCelia J A Morgan, Leslie Muetzelfeldt, Mark Muetzelfeldt, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 24, 2025
The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trialJessica Henry, Bruna Giribaldi, David J Nutt, et al.Pageof 245